The Ureteric Stents Market size was valued at USD 1.3 Billion in 2022 and is projected to reach USD 2.1 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The Ureteric Stents Market is divided into different applications based on the settings in which the procedures are performed. One of the significant applications is in hospitals, where the majority of ureteric stent placements are conducted. Hospitals are often equipped with state-of-the-art medical technologies and facilities, allowing for the treatment of a wide variety of urinary tract issues. These institutions provide the necessary infrastructure for both emergency and elective ureteric stent placements, which are often required due to conditions like kidney stones, urinary tract obstruction, and post-surgical support. The stents help to ensure proper urine flow from the kidneys to the bladder, alleviating blockages and preventing complications such as infections and kidney damage. Due to the complex nature of the procedures and the need for specialized care, hospitals account for a large share of the market for ureteric stents, offering advanced treatment options and comprehensive post-operative care for patients. Furthermore, hospitals are critical centers for training medical professionals and conducting research into advanced ureteric stent technology, contributing to the growth of the market.
Within hospital settings, ureteric stents are used in various departments, including urology, nephrology, and emergency care. These stents play a vital role in managing patients with ureteral obstructions, hydronephrosis, or post-surgical complications. Hospitals benefit from a steady stream of patients requiring stent insertion, and the increasing number of kidney-related issues is expected to drive the demand for these devices. Moreover, hospitals are equipped with multi-disciplinary teams that provide comprehensive care, making them the preferred setting for the use of ureteric stents, particularly for patients requiring continuous monitoring and advanced treatment options. As a result, hospitals are expected to maintain a dominant role in the ureteric stents market, with rising healthcare investments and an aging population further enhancing the demand for these devices.
Ambulatory Surgery Centers (ASCs) represent another key segment in the Ureteric Stents Market, providing an alternative to hospital settings for certain types of procedures. These centers are designed for outpatient surgical procedures and cater to patients who require less extensive post-operative care. The advantage of ASCs is that they offer lower costs compared to traditional hospital settings, which is driving the adoption of ureteric stent placements in these facilities. ASCs are increasingly becoming a popular choice for non-emergency stent insertions and removals, particularly for less complicated cases. These centers have a streamlined operational model, enabling quicker procedures and faster patient recovery times. Furthermore, ASCs can provide specialized care for patients undergoing routine ureteric stent placement, with minimal risk of complications, making them an attractive option for both patients and healthcare providers alike. With the growing preference for outpatient procedures and the reduction in healthcare costs, the demand for ureteric stents in ASCs is expected to rise.
ASCs are particularly advantageous for patients who do not require the full range of inpatient hospital services but still need careful monitoring and skilled intervention. As medical technology advances, many ASCs are now equipped with modern diagnostic tools and operating rooms that are suitable for performing stent placement procedures with high efficiency. The increase in the number of ASCs and their growing acceptance as a viable option for certain medical procedures have led to a noticeable shift in the market dynamics. As patients become more cost-conscious and look for convenient, minimally invasive treatment options, the ureteric stents market in ASCs is projected to experience sustained growth. Additionally, ASCs benefit from reduced overhead costs and shorter patient turnaround times, making them an appealing setting for routine stent procedures and contributing to the overall expansion of the market.
Download In depth Research Report of Ureteric Stents Market
By combining cutting-edge technology with conventional knowledge, the Ureteric Stents market is well known for its creative approach. Major participants prioritize high production standards, frequently highlighting energy efficiency and sustainability. Through innovative research, strategic alliances, and ongoing product development, these businesses control both domestic and foreign markets. Prominent manufacturers ensure regulatory compliance while giving priority to changing trends and customer requests. Their competitive advantage is frequently preserved by significant R&D expenditures and a strong emphasis on selling high-end goods worldwide.
Boston Scientific
Olympus
Bard Medical
Coloplast
B. Braun
Applied Medical
Cook Medical
Teleflex
Medi-Globe
Optimed
Boston Scientific
North America (United States, Canada, and Mexico, etc.)
Asia-Pacific (China, India, Japan, South Korea, and Australia, etc.)
Europe (Germany, United Kingdom, France, Italy, and Spain, etc.)
Latin America (Brazil, Argentina, and Colombia, etc.)
Middle East & Africa (Saudi Arabia, UAE, South Africa, and Egypt, etc.)
For More Information or Query, Visit @ Ureteric Stents Market Size And Forecast 2024-2030
Several key trends are shaping the Ureteric Stents Market. One of the most prominent trends is the increasing adoption of minimally invasive procedures. As surgical techniques improve, the need for invasive surgeries has decreased, leading to a greater demand for ureteric stents as a less invasive method of managing urinary tract obstructions. This trend is fueled by advancements in stent designs, which now offer more comfortable and efficient options for patients. Stents with enhanced biocompatibility, reduced complications, and longer retention periods are gaining popularity in the market. The development of next-generation ureteric stents, such as those coated with antimicrobial agents or designed with more flexible materials, is also expected to drive growth in the market, as these innovations reduce the likelihood of stent-related complications and improve patient outcomes.
Another significant trend is the growing prevalence of kidney-related diseases, such as chronic kidney disease (CKD) and kidney stones, which is driving the demand for ureteric stents. As populations age and lifestyle factors contribute to the rise in kidney disorders, there is a greater need for effective treatments that can manage these conditions without resorting to more invasive surgical options. The rise in the number of patients seeking outpatient care and elective procedures is also contributing to the growing popularity of ambulatory surgery centers (ASCs), which offer a more cost-effective alternative to traditional hospital settings. Additionally, there is a shift towards personalized medicine, with an increasing focus on tailoring stent treatments to individual patient needs, further influencing the market dynamics and leading to the development of customized ureteric stents that cater to specific conditions and patient profiles.
The Ureteric Stents Market presents numerous opportunities, particularly in the development of innovative stent technologies that address current limitations. For example, the introduction of stents with drug-eluting coatings to prevent infections or reduce inflammation is a significant opportunity for manufacturers. These new products can help to improve patient outcomes and reduce the risks of complications, thereby making ureteric stents more appealing to both healthcare providers and patients. Furthermore, advancements in 3D printing technology have opened the door to creating custom-designed ureteric stents that can be tailored to the unique anatomical needs of individual patients. This level of personalization is expected to drive demand for ureteric stents, particularly in specialized treatment centers and hospitals where complex cases are handled.
Another promising opportunity lies in the expansion of healthcare infrastructure, particularly in emerging markets. As healthcare access improves in regions such as Asia-Pacific and Latin America, the demand for medical devices, including ureteric stents, is expected to grow. In these markets, the increasing burden of kidney-related diseases, coupled with the rising healthcare expenditure, is likely to lead to a surge in stent adoption. Companies that focus on penetrating these underserved markets through strategic partnerships and localized manufacturing can take advantage of this growing demand. Additionally, the increasing awareness of kidney diseases and the need for early diagnosis and treatment is another opportunity for stakeholders in the ureteric stents market to position themselves as leaders in innovation and patient care.
1. What is a ureteric stent?
A ureteric stent is a flexible tube inserted into the ureter to prevent or treat blockages and ensure proper urine flow from the kidneys to the bladder.
2. How long can a ureteric stent remain in place?
Typically, a ureteric stent can stay in place for 4 to 6 weeks, but the duration depends on the patient's condition and the type of stent used.
3. Are there any risks associated with ureteric stents?
Potential risks include infection, pain, stent migration, or the formation of stones around the stent. However, these complications are relatively rare with proper care.
4. Can ureteric stents be used for kidney stones?
Yes, ureteric stents are often used to treat kidney stones by allowing urine to pass around the stone and relieve any blockage caused by it.
5. How is a ureteric stent inserted?
A ureteric stent is typically inserted using a cystoscope or through a small incision, often under local or general anesthesia.
6. What is the recovery time after ureteric stent placement?
Most patients experience mild discomfort for a few days, but recovery time is generally short, and many patients can return to normal activities within a week.
7. Can ureteric stents cause urinary tract infections (UTIs)?
Although rare, ureteric stents can increase the risk of UTIs due to bacteria entering through the stent. Prophylactic antibiotics may be prescribed to reduce this risk.
8. Are there different types of ureteric stents?
Yes, ureteric stents vary in material (such as silicone or polyurethane), length, diameter, and design, depending on the patient’s specific needs.
9. What role do ambulatory surgery centers play in the ureteric stent market?
Ambulatory surgery centers (ASCs) provide cost-effective and efficient outpatient procedures, including ureteric stent insertions and removals, catering to less complex cases.
10. How can the Ureteric Stents Market benefit from advancements in technology?
Technological innovations like drug-eluting stents, 3D printing, and personalized care options provide opportunities to enhance treatment outcomes and market growth.